Nyrada (NYR) Short Interest
Nyrada (ASX:NYR) had 0.00% of shares reported as short positions as of 15 June 2026, representing 3,323 shares. Nyrada operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Nyrada
Drug research and development
Short position
Nyrada (ASX:NYR) has 0.00% of its shares on issue reported as short positions as of 15 June 2026, or about 3,323 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. NYR is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Weekly context: The 10 most shorted ASX stocks — Week 34, 2026.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4NYR intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
About
website
address
More Pharmaceuticals, Biotechnology & Life Sciences Stocks
Other shorted stocks in this sector
Be the first to discuss NYR
Start a research thread or post the first pulse update